Authors:
POOLEWILSON P
CLELAND J
HUBBARD W
SUTTON G
PITTARD J
OSBORNE C
LONG C
INGHAM S
ROBINSON P
BALL S
HAMPTON J
POULTER N
MURRAY G
TRAVILL C
BAIN RJ
BAKSI A
BAXTER RH
BEEN A
BERKIN KE
BLACKWOOD R
BLANDFORD RL
BOYLE RM
BUCHALTER M
CAMPBELL R
CHALLENOR V
CHEADLE B
COATS A
COLLINS P
COWAN C
CREAMER J
DANCY CM
DAVIES J
DAVIES R
EHSANULLIAH M
ELDER A
FOWLER JM
FULCHER RA
GHOSH MK
GREENBAUM RA
GREENWOOD TW
GRIMMER SEM
HARVEY J
HELLER A
HENDERSON AN
HENDRA T
HENDREY WG
HOGAN J
HOLLINRAKE K
HOLT P
HUTTON I
JONES A
JONES I
LEVY R
LEWIS P
LEWIS R
MCCULLOCH A
MCMAHON DG
MCMURRAY JJ
MCNEIL GP
MONDAL BK
MORANT AJ
MURPHY J
MURRAY RG
NORTHCOTE RJ
PATTERSON D
PEASTON MJT
PETRI MP
PIPPEN CAR
PITTSCRICK J
PURI RK
RAJ MVJ
RAO SK
REID C
REITH SBM
RODGER JC
ROZCOVEC A
SETHI P
SHAPIRO L
SILAS J
SKEHAN JD
SMITH D
SMITH RH
TERRY G
THOMAS P
TIMMIS S
WALLER LD
WALTON S
WHALE RJ
WIJAYAWARDHANA UD
WILSON JL
Citation: P. Poolewilson et al., CLINICAL OUTCOME WITH ENALAPRIL IN SYMPTOMATIC CHRONIC HEART-FAILURE - A DOSE COMPARISON, European heart journal, 19(3), 1998, pp. 481-489
Authors:
COBBE SM
RAE AP
POLONIECKI JD
CHONG E
BALNAVE K
MORIARTY A
BLACKWOOD R
CAHILL N
COBBE S
PYE M
SEDGWICK M
COOPER D
FLINT J
GOULD B
HUTCHISON S
IRVINE N
LEWIS P
OKEEFE B
SANDERSON J
RAE A
LIP G
GEMMILL J
SHIU G
SILAS J
WATKINS J
STEPHENS J
Citation: Sm. Cobbe et al., A RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF PROPAFENONE IN THE PROPHYLAXIS OF PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA AND PAROXYSMAL ATRIAL-FIBRILLATION, Circulation, 92(9), 1995, pp. 2550-2557